What a difference a year makes, but analysts remain optimistic
This article was originally published in Clinica
Executive Summary
Short-term, the outlook for the EU medtech industry may be tough, even grim for some companies, as the economic crisis bites and healthcare budget holders are forced to make unpopular cuts. However, the healthcare industry should not lose sight of the bigger picture and the long-term trends that will create a strong demand for its products.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.